ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Juvenile Macular Degeneration Treatment Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-35E5947
Home | Market Reports | People & Society
Global Juvenile Macular Degeneration Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Juvenile Macular Degeneration Treatment Market Research Report 2024

Code: QYRE-Auto-35E5947
Report
August 2024
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Acucela Inc
Alkeus Pharmaceuticals Inc
Astellas Pharma Inc
Copernicus Therapeutics Inc
Grupo Ferrer Internacional SA
Iris Pharma
Sanofi

Juvenile Macular Degeneration Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Juvenile Macular Degeneration Treatment Market

Juvenile Macular Degeneration Treatment Market

The global Juvenile Macular Degeneration Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Juvenile Macular Degeneration Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Juvenile Macular Degeneration Treatment.

Report Scope

The Juvenile Macular Degeneration Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Juvenile Macular Degeneration Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Juvenile Macular Degeneration Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Juvenile Macular Degeneration Treatment Market Report

Report Metric Details
Report Name Juvenile Macular Degeneration Treatment Market
CAGR 5%
Segment by Type
  • Avacincaptad Pegol Sodium
  • Echothiophate Iodide
  • Emixustat Hydrochloride
  • FAB-111
  • Others
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Acucela Inc., Alkeus Pharmaceuticals Inc, Astellas Pharma Inc, Copernicus Therapeutics Inc, Grupo Ferrer Internacional SA, Iris Pharma, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Juvenile Macular Degeneration Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Juvenile Macular Degeneration Treatment Market report?

Ans: The main players in the Juvenile Macular Degeneration Treatment Market are Acucela Inc., Alkeus Pharmaceuticals Inc, Astellas Pharma Inc, Copernicus Therapeutics Inc, Grupo Ferrer Internacional SA, Iris Pharma, Sanofi

What are the Application segmentation covered in the Juvenile Macular Degeneration Treatment Market report?

Ans: The Applications covered in the Juvenile Macular Degeneration Treatment Market report are Clinic, Hospital, Homecare

What are the Type segmentation covered in the Juvenile Macular Degeneration Treatment Market report?

Ans: The Types covered in the Juvenile Macular Degeneration Treatment Market report are Avacincaptad Pegol Sodium, Echothiophate Iodide, Emixustat Hydrochloride, FAB-111, Others

Recommended Reports

Ophthalmology Therapeutics

Retinal Disease Treatment

Neurological Disorders

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Juvenile Macular Degeneration Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Avacincaptad Pegol Sodium
1.2.3 Echothiophate Iodide
1.2.4 Emixustat Hydrochloride
1.2.5 FAB-111
1.2.6 Others
1.3 Market by Application
1.3.1 Global Juvenile Macular Degeneration Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Juvenile Macular Degeneration Treatment Market Perspective (2019-2030)
2.2 Juvenile Macular Degeneration Treatment Growth Trends by Region
2.2.1 Global Juvenile Macular Degeneration Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Juvenile Macular Degeneration Treatment Historic Market Size by Region (2019-2024)
2.2.3 Juvenile Macular Degeneration Treatment Forecasted Market Size by Region (2025-2030)
2.3 Juvenile Macular Degeneration Treatment Market Dynamics
2.3.1 Juvenile Macular Degeneration Treatment Industry Trends
2.3.2 Juvenile Macular Degeneration Treatment Market Drivers
2.3.3 Juvenile Macular Degeneration Treatment Market Challenges
2.3.4 Juvenile Macular Degeneration Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Juvenile Macular Degeneration Treatment Players by Revenue
3.1.1 Global Top Juvenile Macular Degeneration Treatment Players by Revenue (2019-2024)
3.1.2 Global Juvenile Macular Degeneration Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Juvenile Macular Degeneration Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Juvenile Macular Degeneration Treatment Revenue
3.4 Global Juvenile Macular Degeneration Treatment Market Concentration Ratio
3.4.1 Global Juvenile Macular Degeneration Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Juvenile Macular Degeneration Treatment Revenue in 2023
3.5 Juvenile Macular Degeneration Treatment Key Players Head office and Area Served
3.6 Key Players Juvenile Macular Degeneration Treatment Product Solution and Service
3.7 Date of Enter into Juvenile Macular Degeneration Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Juvenile Macular Degeneration Treatment Breakdown Data by Type
4.1 Global Juvenile Macular Degeneration Treatment Historic Market Size by Type (2019-2024)
4.2 Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Type (2025-2030)
5 Juvenile Macular Degeneration Treatment Breakdown Data by Application
5.1 Global Juvenile Macular Degeneration Treatment Historic Market Size by Application (2019-2024)
5.2 Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Juvenile Macular Degeneration Treatment Market Size (2019-2030)
6.2 North America Juvenile Macular Degeneration Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Juvenile Macular Degeneration Treatment Market Size by Country (2019-2024)
6.4 North America Juvenile Macular Degeneration Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Juvenile Macular Degeneration Treatment Market Size (2019-2030)
7.2 Europe Juvenile Macular Degeneration Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Juvenile Macular Degeneration Treatment Market Size by Country (2019-2024)
7.4 Europe Juvenile Macular Degeneration Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size (2019-2030)
8.2 Asia-Pacific Juvenile Macular Degeneration Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Juvenile Macular Degeneration Treatment Market Size (2019-2030)
9.2 Latin America Juvenile Macular Degeneration Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Juvenile Macular Degeneration Treatment Market Size by Country (2019-2024)
9.4 Latin America Juvenile Macular Degeneration Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size (2019-2030)
10.2 Middle East & Africa Juvenile Macular Degeneration Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acucela Inc.
11.1.1 Acucela Inc. Company Detail
11.1.2 Acucela Inc. Business Overview
11.1.3 Acucela Inc. Juvenile Macular Degeneration Treatment Introduction
11.1.4 Acucela Inc. Revenue in Juvenile Macular Degeneration Treatment Business (2019-2024)
11.1.5 Acucela Inc. Recent Development
11.2 Alkeus Pharmaceuticals Inc
11.2.1 Alkeus Pharmaceuticals Inc Company Detail
11.2.2 Alkeus Pharmaceuticals Inc Business Overview
11.2.3 Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Introduction
11.2.4 Alkeus Pharmaceuticals Inc Revenue in Juvenile Macular Degeneration Treatment Business (2019-2024)
11.2.5 Alkeus Pharmaceuticals Inc Recent Development
11.3 Astellas Pharma Inc
11.3.1 Astellas Pharma Inc Company Detail
11.3.2 Astellas Pharma Inc Business Overview
11.3.3 Astellas Pharma Inc Juvenile Macular Degeneration Treatment Introduction
11.3.4 Astellas Pharma Inc Revenue in Juvenile Macular Degeneration Treatment Business (2019-2024)
11.3.5 Astellas Pharma Inc Recent Development
11.4 Copernicus Therapeutics Inc
11.4.1 Copernicus Therapeutics Inc Company Detail
11.4.2 Copernicus Therapeutics Inc Business Overview
11.4.3 Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Introduction
11.4.4 Copernicus Therapeutics Inc Revenue in Juvenile Macular Degeneration Treatment Business (2019-2024)
11.4.5 Copernicus Therapeutics Inc Recent Development
11.5 Grupo Ferrer Internacional SA
11.5.1 Grupo Ferrer Internacional SA Company Detail
11.5.2 Grupo Ferrer Internacional SA Business Overview
11.5.3 Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Introduction
11.5.4 Grupo Ferrer Internacional SA Revenue in Juvenile Macular Degeneration Treatment Business (2019-2024)
11.5.5 Grupo Ferrer Internacional SA Recent Development
11.6 Iris Pharma
11.6.1 Iris Pharma Company Detail
11.6.2 Iris Pharma Business Overview
11.6.3 Iris Pharma Juvenile Macular Degeneration Treatment Introduction
11.6.4 Iris Pharma Revenue in Juvenile Macular Degeneration Treatment Business (2019-2024)
11.6.5 Iris Pharma Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Juvenile Macular Degeneration Treatment Introduction
11.7.4 Sanofi Revenue in Juvenile Macular Degeneration Treatment Business (2019-2024)
11.7.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Acucela Inc
Alkeus Pharmaceuticals Inc
Astellas Pharma Inc
Copernicus Therapeutics Inc
Grupo Ferrer Internacional SA
Iris Pharma
Sanofi
List of Tables
    Table 1. Global Juvenile Macular Degeneration Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Avacincaptad Pegol Sodium
    Table 3. Key Players of Echothiophate Iodide
    Table 4. Key Players of Emixustat Hydrochloride
    Table 5. Key Players of FAB-111
    Table 6. Key Players of Others
    Table 7. Global Juvenile Macular Degeneration Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Juvenile Macular Degeneration Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Juvenile Macular Degeneration Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Juvenile Macular Degeneration Treatment Market Share by Region (2019-2024)
    Table 11. Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Juvenile Macular Degeneration Treatment Market Share by Region (2025-2030)
    Table 13. Juvenile Macular Degeneration Treatment Market Trends
    Table 14. Juvenile Macular Degeneration Treatment Market Drivers
    Table 15. Juvenile Macular Degeneration Treatment Market Challenges
    Table 16. Juvenile Macular Degeneration Treatment Market Restraints
    Table 17. Global Juvenile Macular Degeneration Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Juvenile Macular Degeneration Treatment Market Share by Players (2019-2024)
    Table 19. Global Top Juvenile Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Juvenile Macular Degeneration Treatment as of 2023)
    Table 20. Ranking of Global Top Juvenile Macular Degeneration Treatment Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by Juvenile Macular Degeneration Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Juvenile Macular Degeneration Treatment Product Solution and Service
    Table 24. Date of Enter into Juvenile Macular Degeneration Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Juvenile Macular Degeneration Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Juvenile Macular Degeneration Treatment Revenue Market Share by Type (2019-2024)
    Table 28. Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Juvenile Macular Degeneration Treatment Revenue Market Share by Type (2025-2030)
    Table 30. Global Juvenile Macular Degeneration Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Juvenile Macular Degeneration Treatment Revenue Market Share by Application (2019-2024)
    Table 32. Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Juvenile Macular Degeneration Treatment Revenue Market Share by Application (2025-2030)
    Table 34. North America Juvenile Macular Degeneration Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America Juvenile Macular Degeneration Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America Juvenile Macular Degeneration Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe Juvenile Macular Degeneration Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe Juvenile Macular Degeneration Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe Juvenile Macular Degeneration Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific Juvenile Macular Degeneration Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific Juvenile Macular Degeneration Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America Juvenile Macular Degeneration Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America Juvenile Macular Degeneration Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America Juvenile Macular Degeneration Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa Juvenile Macular Degeneration Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa Juvenile Macular Degeneration Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Acucela Inc. Company Detail
    Table 50. Acucela Inc. Business Overview
    Table 51. Acucela Inc. Juvenile Macular Degeneration Treatment Product
    Table 52. Acucela Inc. Revenue in Juvenile Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
    Table 53. Acucela Inc. Recent Development
    Table 54. Alkeus Pharmaceuticals Inc Company Detail
    Table 55. Alkeus Pharmaceuticals Inc Business Overview
    Table 56. Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Product
    Table 57. Alkeus Pharmaceuticals Inc Revenue in Juvenile Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
    Table 58. Alkeus Pharmaceuticals Inc Recent Development
    Table 59. Astellas Pharma Inc Company Detail
    Table 60. Astellas Pharma Inc Business Overview
    Table 61. Astellas Pharma Inc Juvenile Macular Degeneration Treatment Product
    Table 62. Astellas Pharma Inc Revenue in Juvenile Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
    Table 63. Astellas Pharma Inc Recent Development
    Table 64. Copernicus Therapeutics Inc Company Detail
    Table 65. Copernicus Therapeutics Inc Business Overview
    Table 66. Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Product
    Table 67. Copernicus Therapeutics Inc Revenue in Juvenile Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
    Table 68. Copernicus Therapeutics Inc Recent Development
    Table 69. Grupo Ferrer Internacional SA Company Detail
    Table 70. Grupo Ferrer Internacional SA Business Overview
    Table 71. Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Product
    Table 72. Grupo Ferrer Internacional SA Revenue in Juvenile Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
    Table 73. Grupo Ferrer Internacional SA Recent Development
    Table 74. Iris Pharma Company Detail
    Table 75. Iris Pharma Business Overview
    Table 76. Iris Pharma Juvenile Macular Degeneration Treatment Product
    Table 77. Iris Pharma Revenue in Juvenile Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
    Table 78. Iris Pharma Recent Development
    Table 79. Sanofi Company Detail
    Table 80. Sanofi Business Overview
    Table 81. Sanofi Juvenile Macular Degeneration Treatment Product
    Table 82. Sanofi Revenue in Juvenile Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
    Table 83. Sanofi Recent Development
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Juvenile Macular Degeneration Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Juvenile Macular Degeneration Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Avacincaptad Pegol Sodium Features
    Figure 4. Echothiophate Iodide Features
    Figure 5. Emixustat Hydrochloride Features
    Figure 6. FAB-111 Features
    Figure 7. Others Features
    Figure 8. Global Juvenile Macular Degeneration Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Juvenile Macular Degeneration Treatment Market Share by Application: 2023 VS 2030
    Figure 10. Clinic Case Studies
    Figure 11. Hospital Case Studies
    Figure 12. Homecare Case Studies
    Figure 13. Juvenile Macular Degeneration Treatment Report Years Considered
    Figure 14. Global Juvenile Macular Degeneration Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Juvenile Macular Degeneration Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Juvenile Macular Degeneration Treatment Market Share by Region: 2023 VS 2030
    Figure 17. Global Juvenile Macular Degeneration Treatment Market Share by Players in 2023
    Figure 18. Global Top Juvenile Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Juvenile Macular Degeneration Treatment as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Juvenile Macular Degeneration Treatment Revenue in 2023
    Figure 20. North America Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Juvenile Macular Degeneration Treatment Market Share by Country (2019-2030)
    Figure 22. United States Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Juvenile Macular Degeneration Treatment Market Share by Country (2019-2030)
    Figure 26. Germany Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Juvenile Macular Degeneration Treatment Market Share by Region (2019-2030)
    Figure 34. China Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Juvenile Macular Degeneration Treatment Market Share by Country (2019-2030)
    Figure 42. Mexico Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Juvenile Macular Degeneration Treatment Market Share by Country (2019-2030)
    Figure 46. Turkey Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Juvenile Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Acucela Inc. Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2019-2024)
    Figure 49. Alkeus Pharmaceuticals Inc Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2019-2024)
    Figure 50. Astellas Pharma Inc Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2019-2024)
    Figure 51. Copernicus Therapeutics Inc Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2019-2024)
    Figure 52. Grupo Ferrer Internacional SA Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2019-2024)
    Figure 53. Iris Pharma Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2019-2024)
    Figure 54. Sanofi Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2019-2024)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Macular Degeneration Drug Pipeline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Retinal Disorder Treatment Market Research Report 2024
Global Retinal Disorder Drug Market Research Report 2024
Retinal Dystrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Retinitis Pigmentosa Treatment Market Research Report 2024
Eye Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetic Macular Edema Drug Market Research Report 2024
Global Posterior Segment Eye Disease Treatment Market Research Report 2024
Ophthalmic Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Choroid Therapy Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ocular Drug Delivery Market Research Report 2025
Amblyopia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Eye Inflammation Treatment Market Research Report 2025
Diabetic Retinopathy Fundus Image assisted Diagnosis Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Eye Drug Market Insights Forecast to 2030
Neurodegenerative Disease Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric Oncology Treatment Market Research Report 2025
Global Skin Pigmentation Disorder Treatment Market Research Report 2024
Uveitis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions